NASDAQ:AMTX Aemetis (AMTX) Stock Price, News & Analysis $2.17 +0.04 (+1.64%) As of 12:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Aemetis Stock (NASDAQ:AMTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aemetis alerts:Sign Up Key Stats Today's Range$2.11▼$2.2950-Day Range$1.25▼$2.2652-Week Range$1.22▼$4.73Volume430,410 shsAverage Volume771,488 shsMarket Capitalization$120.43 millionP/E RatioN/ADividend YieldN/APrice Target$13.43Consensus RatingModerate Buy Company OverviewAemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.Read More… Aemetis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreAMTX MarketRank™: Aemetis scored higher than 44% of companies evaluated by MarketBeat, and ranked 532nd out of 807 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingAemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAemetis has only been the subject of 2 research reports in the past 90 days.Read more about Aemetis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aemetis are expected to grow in the coming year, from ($2.07) to ($0.70) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aemetis is -1.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aemetis is -1.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Aemetis' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted17.99% of the float of Aemetis has been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 8.1.Change versus previous monthShort interest in Aemetis has recently decreased by 19.96%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAemetis does not currently pay a dividend.Dividend GrowthAemetis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted17.99% of the float of Aemetis has been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 8.1.Change versus previous monthShort interest in Aemetis has recently decreased by 19.96%, indicating that investor sentiment is improving significantly. News and Social Media1.9 / 5News Sentiment0.42 News SentimentAemetis has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Aemetis this week, compared to 2 articles on an average week.Search InterestOnly 5 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aemetis insiders have not sold or bought any company stock.Percentage Held by Insiders14.70% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.02% of the stock of Aemetis is held by institutions.Read more about Aemetis' insider trading history. Receive AMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter. Email Address AMTX Stock News HeadlinesU.S. biofuel feedstock prices extend gains on EPA blending planJune 17 at 2:55 AM | msn.comAemetis: High Stakes, High Debt, A Speculative Play That Still Needs ProofJune 14, 2025 | seekingalpha.com379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsJune 20, 2025 | True Market Insiders (Ad)Aemetis Insider Trading Activity | NASDAQ:AMTX | BenzingaJune 7, 2025 | benzinga.comAemetis Stock Short Interest Report | NASDAQ:AMTX | BenzingaJune 7, 2025 | benzinga.comAemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy DigestersMay 13, 2025 | globenewswire.comAemetis, Inc. (NASDAQ:AMTX) Analysts Are Pretty Bullish On The Stock After Recent ResultsMay 12, 2025 | finance.yahoo.comAemetis, Inc. (AMTX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comSee More Headlines AMTX Stock Analysis - Frequently Asked Questions How have AMTX shares performed this year? Aemetis' stock was trading at $2.69 at the beginning of 2025. Since then, AMTX shares have decreased by 15.4% and is now trading at $2.2750. View the best growth stocks for 2025 here. How were Aemetis' earnings last quarter? Aemetis, Inc (NASDAQ:AMTX) posted its quarterly earnings results on Thursday, May, 8th. The specialty chemicals company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.39) by $0.08. The specialty chemicals company had revenue of $42.89 million for the quarter, compared to the consensus estimate of $59.35 million. Read the conference call transcript. Who are Aemetis' major shareholders? Aemetis' top institutional shareholders include Goldman Sachs Group Inc. (0.41%), PNC Financial Services Group Inc. (0.21%), Simplex Trading LLC and Nuveen LLC (0.16%). Insiders that own company stock include Naomi Louise Boness and John R Block. View institutional ownership trends. How do I buy shares of Aemetis? Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aemetis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings5/08/2025Today6/20/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorEnergy Industry Biofuels Sub-IndustryChemicals Current SymbolNASDAQ:AMTX CIK738214 Webwww.aemetis.com Phone(408) 213-0940Fax408-252-8044Employees160Year FoundedN/APrice Target and Rating Average Stock Price Target$13.43 High Stock Price Target$28.00 Low Stock Price Target$2.20 Potential Upside/Downside+527.3%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$87.54 million Net Margins-36.92% Pretax Margin-44.70% Return on EquityN/A Return on Assets-35.80% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.03 Sales & Book Value Annual Sales$267.64 million Price / Sales0.44 Cash FlowN/A Price / Cash FlowN/A Book Value($5.16) per share Price / Book-0.41Miscellaneous Outstanding Shares55,370,000Free Float47,230,000Market Cap$118.49 million OptionableOptionable Beta1.48 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:AMTX) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersWhat a “Mar-a-Lago Accord” could mean for the US dollar.25-Year Market Vet Issues Urgent Dollar Warning He's spent 25 years tracking the flow of global money - now...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aemetis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.